Synthesis and biological evaluation of amide derivatives of diflunisal as potential anti-inflammatory agents. 2009

Guang-Xiang Zhong, and Jin-Qing Hu, and Kun Zhao, and Lu-Lu Chen, and Wei-Xiao Hu, and Ming-You Qiu
College of Pharmaceutical Science, Zhejiang University of Technology, 18, Chaowang Road, Hangzhou, Zhejiang 310032, China. drzhonggx@sohu.com

To improve the medicinal activity, the structure of diflunisal has been modified. Twenty-one amide derivatives of diflunisal were synthesized starting from diflunisal in three steps with total yields from 72% to 89%. All compounds were identified by (1)H NMR, MS, and elemental analysis. The anti-inflammatory and analgesic activities for 19 compounds were evaluated. It was found that 5m possesses an excellent anti-inflammatory activity and a good analgesic activity, maybe a potential anti-inflammatory agent.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D004061 Diflunisal A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN. Apo-Diflunisal,Dolobid,Dolobis,Dolocid,MK-647,Novo-Diflunisal,Nu-Diflunisal,Apo Diflunisal,ApoDiflunisal,MK 647,MK647,Novo Diflunisal,NovoDiflunisal,Nu Diflunisal,NuDiflunisal
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass

Related Publications

Guang-Xiang Zhong, and Jin-Qing Hu, and Kun Zhao, and Lu-Lu Chen, and Wei-Xiao Hu, and Ming-You Qiu
February 2018, European journal of medicinal chemistry,
Guang-Xiang Zhong, and Jin-Qing Hu, and Kun Zhao, and Lu-Lu Chen, and Wei-Xiao Hu, and Ming-You Qiu
January 2017, Iranian journal of pharmaceutical research : IJPR,
Guang-Xiang Zhong, and Jin-Qing Hu, and Kun Zhao, and Lu-Lu Chen, and Wei-Xiao Hu, and Ming-You Qiu
April 2013, European journal of medicinal chemistry,
Guang-Xiang Zhong, and Jin-Qing Hu, and Kun Zhao, and Lu-Lu Chen, and Wei-Xiao Hu, and Ming-You Qiu
June 2013, European journal of medicinal chemistry,
Guang-Xiang Zhong, and Jin-Qing Hu, and Kun Zhao, and Lu-Lu Chen, and Wei-Xiao Hu, and Ming-You Qiu
April 2021, RSC medicinal chemistry,
Guang-Xiang Zhong, and Jin-Qing Hu, and Kun Zhao, and Lu-Lu Chen, and Wei-Xiao Hu, and Ming-You Qiu
January 2017, Current pharmaceutical design,
Guang-Xiang Zhong, and Jin-Qing Hu, and Kun Zhao, and Lu-Lu Chen, and Wei-Xiao Hu, and Ming-You Qiu
September 2014, Fitoterapia,
Guang-Xiang Zhong, and Jin-Qing Hu, and Kun Zhao, and Lu-Lu Chen, and Wei-Xiao Hu, and Ming-You Qiu
November 2016, Bioorganic & medicinal chemistry letters,
Guang-Xiang Zhong, and Jin-Qing Hu, and Kun Zhao, and Lu-Lu Chen, and Wei-Xiao Hu, and Ming-You Qiu
March 2004, Bioorganic & medicinal chemistry,
Guang-Xiang Zhong, and Jin-Qing Hu, and Kun Zhao, and Lu-Lu Chen, and Wei-Xiao Hu, and Ming-You Qiu
September 2009, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!